Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.

Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2007 Dec; 38(12):3198-204.

View in: PubMed

subject areas

Aged
Anticholesteremic Agents
Brain
Cholesterol, LDL
Female
Follow-Up Studies
Humans
Ischemic Attack, Transient
Lipids
Male
Middle Aged
Risk
Stroke
Time Factors
Treatment Outcome

authors with profiles

Larry Goldstein